• Login
    View Item 
    •   Home
    • UA Graduate and Undergraduate Research
    • UA Theses and Dissertations
    • Dissertations
    • View Item
    •   Home
    • UA Graduate and Undergraduate Research
    • UA Theses and Dissertations
    • Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UA Campus RepositoryCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsPublisherJournalThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsPublisherJournal

    My Account

    LoginRegister

    About

    AboutUA Faculty PublicationsUA DissertationsUA Master's ThesesUA Honors ThesesUA PressUA YearbooksUA CatalogsUA Libraries

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    5-HT1F Receptor Agonism for the Treatment of Spinal Cord Injury

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    azu_etd_18664_sip1_m.pdf
    Size:
    4.365Mb
    Format:
    PDF
    Download
    Author
    Simmons, Epiphani Ciara
    Issue Date
    2021
    Keywords
    5-HT1F receptor
    blood-spinal cord barrier
    endothelial cells
    mitochondrial biogenesis
    spinal cord injury
    Advisor
    Schnellmann, Rick G.
    
    Metadata
    Show full item record
    Publisher
    The University of Arizona.
    Rights
    Copyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction, presentation (such as public display or performance) of protected items is prohibited except with permission of the author.
    Abstract
    Spinal cord injury (SCI) is characterized by vascular disruption leading to ischemia, decreased oxygen delivery and loss of mitochondrial homeostasis. The dysregulation observed with SCI leads to defective respiratory chain function and reduced ATP production, exacerbating neuronal death and loss of locomotor capability. A growing body of research supports pharmacological induction of mitochondrial biogenesis (MB) as an effective approach to treat SCI. MB is a multifaceted process involving the integration of highly regulated transcriptional events, lipid membrane and protein synthesis/assembly and replication of mitochondrial DNA (mtDNA). We previously identified 5-hydroxytryptamine receptor 1F (5-HT1F) agonism as a potent inducer of MB in multiple organ systems. The series of studies presented herein explores the therapeutic potential of 5-HT1F receptor agonism on MB induction and recovery following SCI using a moderate force-controlled impactor-induced contusion mouse model. Post-SCI, mitochondrial dysfunction presents in the spinal cord, as indicated by decreased mtDNA and mitochondrial protein expression. Daily treatment with LY344864 and lasmiditan, two highly specific 5-HT1F receptor agonists, beginning after injury, not only attenuates these decreases, indicating MB, but also accelerates recovery, as denoted by decreased lesion volume and enhanced locomotor function. 5-HT1F receptor agonism increased locomotor capability, with both LY344864- and lasmiditan-treated mice reaching a Basso-Mouse Scale (BMS) score of ~3.4 by 21d, while vehicle-treated mice exhibited a score of 1.9. Importantly, knockout of the 5-HT1F receptor blocked these effects. Remarkably, a similar degree of locomotor restoration was observed when treatment was initiated 1 or 8h after injury, emphasizing the potential clinical applicability of this therapeutic approach. Furthermore, lasmiditan is FDA-approved for the treatment of migraines and could be repurposed for the treatment of SCI. In addition, injured mice treated with 5-HT1F receptor agonists display decreased Evan’s Blue dye accumulation and increased protein expression of tight junctions in the spinal cord compared to vehicle-treated mice, suggesting enhanced restoration of vascular integrity. These findings led us to investigate if lasmiditan induces MB and function specifically in endothelial cells. In vitro studies determine lasmiditan induces MB and enhances early-phase angiogenic pathways via Akt-eNOS activation in primary cultures of mouse cerebral endothelial cells. These data provide evidence that induction of MB via 5-HT1F receptor agonism may be a promising strategy for the treatment of SCI and related CNS injuries characterized by mitochondrial and vascular dysfunction.
    Type
    text
    Electronic Dissertation
    Degree Name
    Ph.D.
    Degree Level
    doctoral
    Degree Program
    Graduate College
    Neuroscience
    Degree Grantor
    University of Arizona
    Collections
    Dissertations

    entitlement

     
    The University of Arizona Libraries | 1510 E. University Blvd. | Tucson, AZ 85721-0055
    Tel 520-621-6442 | repository@u.library.arizona.edu
    DSpace software copyright © 2002-2017  DuraSpace
    Quick Guide | Contact Us | Send Feedback
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.